NIH-funded research NIH-funded research

Investigating the role of TMEM55B in non-alcoholic fatty liver disease

Official title: TMEM55B as a molecular determinant of NAFLD

Funded at University of California, San Francisco · NIH-10922855 · Data updated 2026-11-12

This study is looking at how a protein called TMEM55B affects non-alcoholic fatty liver disease (NAFLD) to help find new ways to treat this condition that can harm your liver.

More NAFLD research and trials

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionUniversity of California, San Francisco
NIH-funded
Lab location1 site (San Francisco, United States)
Project startSeptember 1, 2023
Project endAugust 31, 2025
Funding year2024
Award (this year)$563,952
NIH project number5R56DK135259-02
Project IDNIH-10922855 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals diagnosed with non-alcoholic fatty liver disease or those at risk for developing it.

Less likely to help

Patients with alcoholic liver disease or those without any liver conditions may not benefit from this research.

What this research studies

This research focuses on understanding how the TMEM55B protein affects non-alcoholic fatty liver disease (NAFLD), a condition that can lead to serious liver issues like cirrhosis. The study examines the molecular mechanisms behind NAFLD by using animal models to observe the effects of TMEM55B on lipid accumulation and liver health. By manipulating TMEM55B levels, researchers aim to uncover how it influences fat mobilization and mitochondrial function in the liver. This could lead to new insights into potential therapeutic targets for treating NAFLD.

Why it matters

Potential benefit: If successful, this research could lead to the development of targeted therapies for non-alcoholic fatty liver disease, improving outcomes for affected patients.

How similar studies have gone: Previous research has shown promising results in understanding the molecular mechanisms of liver diseases, suggesting that this approach could yield valuable insights.

Where this research is happening

  • University of California, San Francisco
    San Francisco, United States
    Active

Researchers

  • Principal investigator: Medina, Marisa Wong — University of California, San Francisco
  • Study coordinator: Medina, Marisa Wong

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.